Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Robert J. Motzer, Bernard Escudier, Saby George et al. · New England Journal of Medicine · 2015 · 5.9K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Bernard Escudier, Camillo Porta, Manuela Schmidinger et al. · Annals of Oncology · 2014 · 2.3K citations · Full text

Medicine, Nephrology, Oncology +14

Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer

Robert C. Flanigan, Sydney E. Salmon, Brent A. Blumenstein et al. · New England Journal of Medicine · 2001 · 1.7K citations

Medicine, Oncology, Surgery +16

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

GHJ Mickisch, A. Garin, Hendrik Van Poppel et al. · The Lancet · 2001 · 1.4K citations

Medicine, Oncology, Surgery +15

American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Performance of Stereotactic Body Radiation Therapy

Louis Potters, Brian D. Kavanagh, James M. Galvin et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 666 citations

Medicine, Oncology, Radiology +16